Revolution Medicines, Inc. (RVMD)

Name: Revolution Medicines, Inc. (RVMD) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Also trades as RVMDW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001628171 · Nasdaq · Biological Products, (No Diagnostic Substances)

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Revolution Medicines, Inc. reported revenue of $0.

Key ratios (year ended 2025-12-31)

-69.3%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Headquarters locality: Redwood City · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Revenue	n/a	$0	$0	$11.58M	$35.38M	$29.39M	$42.98M	$50.04M	$20.16M
R&D Expense	$1.30B	$987.33M	$592.23M	$423.14M	$253.07M	$186.95M	$132.25M	$91.75M	$51.08M
Operating Income	-$1.63B	-$1.18B	-$689.52M	-$487.19M	-$258.28M	-$188.01M	-$110.70M	-$54.12M	-$40.33M
Depreciation & Amortization	n/a	$7.78M	$6.56M	$5.04M	$3.97M	$3.08M	$2.61M	$2.27M	$1.57M
EBITDA	n/a	-$1.17B	-$682.97M	-$482.14M	-$254.31M	-$184.93M	-$108.09M	-$51.85M	-$38.76M
Net Income	-$1.77B	-$1.13B	-$600.09M	-$436.37M	-$248.71M	-$187.09M	-$108.16M	-$47.66M	-$41.79M
EPS (Diluted)	n/a	-$5.95	-$3.58	-$3.86	-$3.08	-$2.57	-$2.01	n/a	n/a
Total Assets	$4.32B	$2.35B	$2.56B	$2.06B	$811.93M	$737.99M	$567.40M	$220.53M	n/a
Total Liabilities	$1.72B	$723.21M	$293.10M	$235.51M	$126.74M	$135.42M	$92.72M	$67.99M	n/a
Shareholders' Equity	$2.61B	$1.63B	$2.27B	$1.83B	$685.19M	$602.57M	$474.68M	-$152.57M	-$108.42M
Cash & Equivalents	$815.43M	$383.75M	$543.06M	$696.15M	$161.41M	$108.50M	$104.27M	$16.66M	$69.59M
Operating Cash Flow	-$1.22B	-$897.74M	-$557.44M	-$350.57M	-$224.40M	-$147.18M	-$100.06M	-$49.62M	$1.21M
Capital Expenditures	$9.10M	$15.99M	$10.31M	$7.73M	$10.82M	$6.53M	$2.93M	$2.59M	$1.50M
Free Cash Flow	-$1.23B	-$913.73M	-$567.74M	-$358.30M	-$235.22M	-$153.71M	-$103.00M	-$52.20M	-$286.0K
Dividends Paid	n/a	n/a	n/a	n/a	n/a	n/a	$0	n/a	n/a
Shares Outstanding	214.24M	197.00M	185.90M	164.67M	90.41M	74.14M	66.60M	3.29M	n/a
Weighted Average Diluted Shares	n/a	190.13M	167.74M	113.15M	80.63M	72.81M	54.87M	n/a	n/a
EPS (Basic)	n/a	-$5.95	-$3.58	-$3.86	-$3.08	-$2.57	-$2.01	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView